Operating cash burn widened to NZD 15.8m as revenue fell 20.0%

Net operating cash outflow widened to NZD 15.8m from NZD 1.4m in HY23, an absolute deterioration of NZD 14.5m. The cash balance only held steady at NZD 18.8m (versus NZD 18.5m prior) because total equity rose 31.5% to NZD 48.7m, indicating a capital injection during the period.

Revenue fell 20.0% to NZD 39.0m. The business swung from a NZD 1.3m profit before tax to a NZD 1.6m loss (PBT growth of -222.8%), and NPAT moved to a NZD 1.7m loss (-267.5%). Capex stepped up to NZD 2.0m from NZD 1.6m, taking pre-lease free cash flow to roughly -NZD 17.8m.

On the balance sheet, inventory days extended to 98.6 from 78.6 (+20.0 days) and receivable days to 51.1 from 45.7. Trade debtors actually fell 10.3%, so the working-capital absorption is concentrated in inventory.

• A NZD 14.5m widening of operating cash outflow against a NZD 2.7m swing in NPAT means the loss substantially understates the cash impact. This matters because the operation consumed the large majority of pre-existing liquidity in a single half, and only a share-issue-sized lift in equity kept the cash line flat.
• Inventory build sits behind the cash drain. Inventory days rose by roughly 20 days while revenue fell 20.0%, so absolute stock holdings (NZD 21.1m) are now disproportionate to current run-rate sales. Combined with management's commentary about supply constraints affecting "ability to grow revenue," this looks like product mix and availability problems rather than over-ordering — but it ties up working capital regardless.
• The reported loss flatters the operating picture. The current effective tax rate of -5.8% (versus +22.5% prior) means the tax line did not provide its usual cushion; PBT growth of -222.8% is the cleaner read than NPAT growth of -267.5%, but both confirm the operation is unprofitable at this revenue level. ROE moved to -3.4% from +2.7%.

Management commentary points to "pending near-term return of full production volumes" and a "corresponding lift in revenue," and references a stated goal to return to dividends by FY26 — but no dated revenue, margin, or cash target is supplied.

The HY23 share of FY23 revenue was 103.3%, indicating FY23 was first-half-weighted because of cyclone-related disruption in the second half. That makes HY24 a poor like-for-like base for projecting FY24, and the release does not provide enough information to model second-half recovery beyond management's qualitative statements.

The headline loss is real, but the cash result is materially worse than the P&L suggests: pre-lease free cash flow of -NZD 17.8m against an NPAT of -NZD 1.7m gives an FCF/NPAT ratio of roughly n/m (i.e., cash outflow ten times the accounting loss). The driver is balance-sheet absorption rather than non-cash charges reversing favourably.

Capex at 5.1% of revenue is up from 3.3%, so investing cash demand is also rising as revenue contracts. The equity-funded liquidity position is the single reason this result does not show up as an acute cash problem; durability of the business model now depends on (a) production volumes returning as management asserts, and (b) the inventory position converting to revenue rather than requiring write-downs. Neither is demonstrated in this release.

This briefing cannot assess production-volume recovery timing, inventory saleability, or the sufficiency of the current cash balance against forward operating needs because the release does not quantify forward orders, capacity restoration, or working-capital normalisation.